Each day the AI scans 100 stocks across sectors and surfaces only the strongest long-term Buys.
Last scan: 10/14/2026, 1:00:14 PM
#1
V
Buy
Visa Inc. · Information Technology
$396.06
85% confidence
Long-term compounder
Visa benefits from secular growth in digital payments and an unparalleled global network effect. This enables consistent revenue growth and high margins, driving shareholder returns over decades.
Long-Term Outlook · 1–5 yrs
Visa’s dominant network, global transaction growth, and strong free cash flow generation support continued long-term compounding. Its moat is exceptionally wide, ensuring sustained profitability.
Bullish Factors
Dominant global payment network
Secular shift to digital payments
Strong free cash flow generation
Key Risks
Regulatory intervention
Cybersecurity threats
Premium valuation justified by quality and growth prospects.
Volatility: low
#2
ORCL
Buy
Oracle Corporation · Technology
$137.39
80% confidence
Long-term compounder
ORCL combines deep enterprise software dominance with a growing cloud and AI segment, offering stable cash flows and future expansion. The recent price dip provides an attractive entry point for both short-term rebound and long-term accumulation.
Long-Term Outlook · 1–5 yrs
Oracle is a mature, cash-generative enterprise software leader transitioning to cloud, with a strong recurring revenue base. Its AI investments and potential for margin expansion support long-term growth.
Bullish Factors
Strong recurring revenue model
Expanding cloud infrastructure (OCI)
Significant AI investment opportunity
Market leader in enterprise software
Key Risks
Execution risk on cloud transition
Economic downturn impacting IT spend
Valued reasonably for its market position and growth prospects after recent pullback.
Volatility: medium
#3
AMAT
Buy
Applied Materials, Inc. · Technology
$464.24
80% confidence
Long-term compounder
AMAT holds a critical position in the semiconductor equipment supply chain, ensuring sustained demand as chip technology advances. Its strong market share and R&D investment create a durable competitive advantage.
Long-Term Outlook · 1–5 yrs
AMAT is a critical enabler of semiconductor manufacturing, benefiting from secular growth in AI and advanced chip demand, with a strong moat and robust free cash flow generation for long-term compounding.
Bullish Factors
Indispensable to semiconductor fabrication
Secular growth drivers: AI, IoT, advanced nodes
Strong balance sheet and cash flow
Diversified customer base globally
Key Risks
Global economic slowdown
Intense competition
Currently trading at a reasonable multiple relative to its growth prospects and market position.
Volatility: high
#4
TGT
Buy
Target Corporation · Retail - Discount Stores
$153.62
80% confidence
Quality at fair price
Target's strong brand, dividend history, and effective omnichannel strategy provide a defensive long-term investment. Short-term, the stock is oversold within its recent trading range, presenting a rebound opportunity.
Long-Term Outlook · 1–5 yrs
Target offers a strong brand, dividend growth, and diversified omnichannel strategy for long-term value appreciation.
Bullish Factors
Omnichannel strength and store remodels
Consistent dividend growth and buybacks
Strong brand loyalty and household penetration
Key Risks
Economic recession impact
Competitive pressures
Reasonable valuation given stable earnings and dividend yield.
Volatility: medium
#5
MU
Buy
Micron Technology, Inc. · Technology
$953.19
80% confidence
Cyclical opportunity
Micron is emerging from a cyclical downturn with strong tailwinds from AI and HBM demand, promising significant revenue and earnings growth. The current price presents an attractive entry for long-term investors despite recent volatility.
Long-Term Outlook · 1–5 yrs
Micron is well-positioned for the secular growth of AI-driven memory demand, benefiting from improved industry supply/demand dynamics and a robust product roadmap, warranting a long-term accumulation.
Bullish Factors
Strong AI and HBM memory demand
Improved DRAM/NAND pricing power
Operating leverage as cycle recovers
Key Risks
Supply/demand imbalance
Competition pressure
Valuation appears reasonable given the anticipated growth trajectory into the AI memory boom.
Volatility: high
#6
OXY
Buy
Occidental Petroleum Corporation · Energy
$61.13
80% confidence
Cyclical opportunity
OXY benefits from its low-cost Permian Basin assets and strategic carbon capture initiatives. Strong balance sheet improvement and disciplined capital allocation underpin long-term value.
Long-Term Outlook · 1–5 yrs
OXY offers compelling value as a leading oil producer with a robust asset base, deleveraging efforts, and potential for sustained free cash flow generation.
Bullish Factors
Leading Permian Basin operator
Significant debt reduction progress
Strategic carbon capture initiatives
Key Risks
Oil price volatility
Regulatory environment changes
OXY is trading at a reasonable valuation relative to its cash flow potential and assets.
Volatility: medium
#7
TMO
Buy
Thermo Fisher Scientific Inc · Healthcare
$663.04
80% confidence
Long-term compounder
TMO's essential role in life science R&D and diagnostics, combined with strategic acquisitions, ensures durable growth and market leadership. Strong cash flow supports continued innovation and shareholder returns.
Long-Term Outlook · 1–5 yrs
TMO is a high-quality, diversified life sciences leader with a strong moat and consistent growth, well-positioned for secular demand in healthcare innovation.
Bullish Factors
Dominant market position in life sciences
Consistent revenue and EPS growth
High switching costs for customers
Key Risks
Regulatory changes
Economic downturn impacting R&D
Premium valuation justified by market leadership and growth trajectory.
Volatility: medium
#8
VRTX
Buy
Vertex Pharmaceuticals Incorpor · Biotechnology
$485.22
80% confidence
Long-term compounder
Vertex is a cash-rich, high-margin pharmaceutical leader with a dominant position in cystic fibrosis and a robust, diversified pipeline leveraging advanced gene therapies. The recent price dip offers an entry point for both short-term rebound and long-term accumulation.
Long-Term Outlook · 1–5 yrs
Vertex's strong cash flow, market leadership in CF, and promising pipeline in gene editing (CRISPR/Cas9) and other areas position it for sustained long-term growth and margin expansion, especially post-acquisition integration.
Bullish Factors
Monopoly in cystic fibrosis market
Strong pipeline, including gene editing (CRISPR)
Excellent profitability and cash flow generation
Key Risks
Clinical trial failures
Increased competition
Reasonably valued given its growth prospects and market leadership.
Volatility: medium
#9
AVGO
Buy
Broadcom Inc. · Technology
$357.31
75% confidence
Long-term compounder
Broadcom consistently executes a successful acquisition-driven strategy, integrating critical infrastructure assets to generate strong free cash flow and deliver shareholder value. Its market leadership in core segments provides a significant moat.
Long-Term Outlook · 1–5 yrs
AVGO's strategic acquisitions and leadership in critical semiconductor and software infrastructure ensure durable cash flows and growth.
Bullish Factors
Dominant position in key markets
Strong free cash flow generation
Accretive acquisition strategy
High switching costs for customers
Key Risks
Economic downturn impacting demand
Regulatory scrutiny on M&A
Reasonably valued given its market position and growth prospects, with potential for further multiple expansion.
Volatility: medium
#10
UPS
Buy
United Parcel Service, Inc. · Industrials
$94.79
75% confidence
Value recovery play
UPS offers a compelling long-term value proposition due to its essential infrastructure and robust cash flow generation. The recent price dip brings it to an attractive short-term technical bounce point and a strong long-term entry.
Long-Term Outlook · 1–5 yrs
UPS is a foundational logistics asset with strong free cash flow and a healthy dividend yield, currently trading at a compelling valuation below historical averages, indicating a long-term value recovery play.
Bullish Factors
Essential global logistics infrastructure
Attractive valuation multiples post-correction
Strong free cash flow generation
High dividend yield at current prices
Key Risks
Economic downturns impact volume
Competitive pricing pressures
Trades below historical P/E and EV/EBITDA, reflecting market concerns but offering value.
Volatility: medium
#11
UNP
Buy
Union Pacific Corporation · Industrials
$281.57
75% confidence
Long-term compounder
Union Pacific's indispensable rail network provides a significant competitive moat and pricing power, ensuring stable cash flows and dividend growth for patient investors. While current valuation is fair, its operational efficiency and economic leverage support continued value creation.
Long-Term Outlook · 1–5 yrs
UNP is a foundational railroad with a wide moat, essential infrastructure, and consistent dividend growth, positioning it well for long-term compounding.
Bullish Factors
Economic moat from rail infrastructure
Consistent dividend growth history
Strong pricing power in key routes
Key Risks
Economic downturns impact volume
Regulatory pressures on operations
Valuation is fair, reflecting its quality and moat, but not deeply discounted.
Volatility: low
#12
COF
Buy
Capital One Financial Corporation · Financials
$198.07
75% confidence
Value recovery play
Capital One offers a compelling long-term value proposition driven by its digital-first strategy and diversified lending portfolio. The current price presents an attractive entry point for patient investors.
Long-Term Outlook · 1–5 yrs
COF has a strong brand in consumer lending and digital banking, offering value after a multi-year underperformance, poised for long-term growth as credit conditions stabilize.
Bullish Factors
Strong digital banking presence
Diversified consumer lending portfolio
Attractive valuation after underperformance
Key Risks
Economic downturn impacts credit
Increased competition in digital banking
The stock trades at a discount to its intrinsic value given its market position and future growth prospects.
Volatility: medium
#13
COP
Buy
ConocoPhillips · Energy
$140.90
75% confidence
Quality at fair price
ConocoPhillips combines strong operational efficiency and a disciplined capital allocation strategy, making it a compelling long-term energy play. Short-term, it exhibits strong momentum after breaking its 30-day range high.
Long-Term Outlook · 1–5 yrs
BUY for long-term; COP's focus on high-margin, low-decline assets and shareholder returns provides a resilient investment in the energy sector.
Bullish Factors
Disciplined capital allocation
High-quality asset portfolio
Strong shareholder returns
Key Risks
Oil price collapse
Regulatory headwinds
Trades at a reasonable multiple given its quality assets and cash flow generation.
Volatility: medium
#14
PG
Buy
Procter & Gamble Company (The) · Consumer Staples
$153.04
75% confidence
Long-term compounder
PG's dominant brand portfolio and global reach ensure stable earnings and cash flow generation, providing a defensive long-term investment. Its resilience allows for consistent dividend growth and market share protection.
Long-Term Outlook · 1–5 yrs
PG remains a robust long-term compounder with a strong brand portfolio, consistent cash flows, and reliable dividend growth, offering defensive stability and quality at a reasonable price.
Bullish Factors
Global market leadership
Strong brand portfolio
Consistent dividend growth
Key Risks
Increased input costs
Shifting consumer preferences
Valuation is currently fair, reflecting its premium quality and defensive characteristics.
Volatility: low
#15
DHR
Buy
Danaher Corporation · Healthcare
$222.84
75% confidence
Long-term compounder
Danaher consistently grows through strategic acquisitions and operational excellence in fragmented, growing healthcare markets. Its strong balance sheet and proven business system drive sustainable shareholder returns.
Long-Term Outlook · 1–5 yrs
DHR is a high-quality compounder with a strong track record of M&A, innovation, and capital allocation in essential life science and diagnostics markets. Its diversified portfolio and strong cash flow generation support long-term value creation.
Bullish Factors
Strong portfolio of essential life science tools
Proven Danaher Business System (DBS)
Consistent M&A engine for growth
Key Risks
Regulatory changes in healthcare
Competitive pressures
Currently appears fairly to slightly overvalued given recent price appreciation.
Volatility: medium
#16
ABNB
Buy
Airbnb, Inc. · Consumer Discretionary
$163.50
75% confidence
Quality at fair price
Airbnb possesses a strong brand, network effect moat, and a capital-light business model allowing for sustained growth and profitability in the expanding travel industry. Current valuation offers a reasonable entry point for long-term investors.
Long-Term Outlook · 1–5 yrs
Airbnb's strong brand, network effects, and capital-light model provide a durable moat for continued growth in the global travel market.
Bullish Factors
Dominant platform in alternative lodging
Capital-light business model, high margins
Expanding into new travel experiences
Key Risks
Regulatory changes impacting hosts
Economic downturn reducing travel
Reasonable entry for a quality growth company, trading below peak multiples.
Volatility: medium
#17
BMY
Buy
Bristol-Myers Squibb Company · Pharmaceuticals
$56.67
70% confidence
Value recovery play
BMY presents a compelling value opportunity after a significant dip, trading at multi-year lows despite a robust pipeline and strong dividend yield. Long-term upside is driven by pipeline execution and multiple expansion.
Long-Term Outlook · 1–5 yrs
BUY for long-term value given the deep valuation, strong pipeline potential, and consistent cash flow generation despite patent cliffs.
Bullish Factors
Deeply discounted valuation metrics
Strong free cash flow generation
Promising late-stage pipeline assets
Key Risks
Pipeline failures
Integration risks
Trades at a significant discount to peers and historical averages.
Volatility: medium
#18
ABBV
Buy
AbbVie Inc. · Healthcare
$274.36
70% confidence
Long-term compounder
AbbVie has successfully navigated patent cliffs, demonstrating pipeline strength and strategic acquisitions. This solidifies its position as a durable pharmaceutical leader with reliable cash flows and dividend growth.
Long-Term Outlook · 1–5 yrs
AbbVie's robust pipeline, successful diversification beyond Humira, and strong cash flow generation support sustained long-term growth and dividend stability, making it an attractive pharmaceutical investment. Valuation remains reasonable for its quality and growth prospects.
Consistent free cash flow generation for dividends
Key Risks
Clinical trial failures
Increased generic competition
The stock appears reasonably valued given its earnings power, pipeline, and dividend yield.
Volatility: medium
#19
FDX
Buy
FedEx Corporation · Industrials
$290.59
70% confidence
Quality at fair price
FedEx, a global logistics leader, is executing a profitable growth strategy through network optimization and digital transformation. Its essential infrastructure supports continued e-commerce expansion and global trade.
Long-Term Outlook · 1–5 yrs
FDX's strategic initiatives, network optimization, and e-commerce tailwinds position it for long-term growth and margin expansion, making current valuation attractive.
Bullish Factors
Network 2.0 integration improving efficiency
Strong free cash flow generation potential
Beneficiary of global e-commerce growth
Key Risks
Fuel price volatility
Labor cost increases
Current valuation appears reasonable given its strategic improvements and market position.
Volatility: medium
#20
DKNG
Buy
DraftKings Inc. · Consumer Discretionary
$19.72
70% confidence
High-risk/high-reward
DraftKings is a market leader in a rapidly growing, nascent industry with significant TAM. Improved operational efficiency and scale should drive future profitability.
Long-Term Outlook · 1–5 yrs
DraftKings holds a leading position in the expanding US online sports betting and iGaming market, with improving unit economics and a path to profitability. The long-term thesis is driven by market share gains and continued state legalization.
Bullish Factors
Leading market share in OSB/iGaming
Expanding legalization across US states
Improving unit economics and operating leverage
Key Risks
Increased competition
Slowed state legalization
Valuation is stretched but justifiable by high growth and market leadership.